Moore Capital Management’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

Moore Capital Management’s Portfolio OACCU Stock Details OACCU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-525,000	Closed	-$5.45M	–	686
2025 Q1	$5.45M	Hold	525,000	–	–	0.11%	176
2024 Q4	$5.33M	Buy	+525,000	New	+$5.29M	0.06%	245

Other funds holding OACCU

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Moore Capital Management's OACCU Position: Q2 2025 in Review

Moore Capital Management sold out of Oaktree Acquisition Corp III Life Sciences Unit (OACCU) in Q2 2025, closing a stake of 525,000 shares — an estimated $5.45M sold.

Moore Capital Management first reported a position in OACCU in Q4 2024 and held it in 2 quarters. The position peaked at $5.45M in Q1 2025. 6 funds tracked by Wall St. Rank hold OACCU as of Q2 2025.

Moore Capital Management reported no remaining Oaktree Acquisition Corp III Life Sciences Unit position as of Q2 2025 after selling out during the quarter.
Moore Capital Management sold 525,000 Oaktree Acquisition Corp III Life Sciences Unit shares in Q2 2025, an estimated $5.45M.
Moore Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q4 2024 and held it in 2 quarters.
Moore Capital Management's Oaktree Acquisition Corp III Life Sciences Unit position peaked at $5.45M in Q1 2025.
6 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q2 2025.

Based on Moore Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.